Affymax (AFFY)
(Delayed Data from OTC)
$0.00 USD
0.00 (0.00%)
Updated Sep 23, 2024 01:29 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Affymax Inc. [AFFY]
Reports for Purchase
Showing records 1 - 20 ( 55 total )
Company: Affymax Inc.
Industry: Medical - Biomedical and Genetics
We are terminating research coverage due to the termination or loss of the primary and/or secondary analysts responsible for coverage.
Provider: DAWSON JAMES SECURITIES, INC.
Company: Affymax Inc.
Industry: Medical - Biomedical and Genetics
Company: Affymax Inc.
Industry: Medical - Biomedical and Genetics
Company: Affymax Inc.
Industry: Medical - Biomedical and Genetics
What Was Supposed to Be a Quiet Week Turns Into a Busy Week
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Affymax Inc.
Industry: Medical - Biomedical and Genetics
Company: Affymax Inc.
Industry: Medical - Biomedical and Genetics
Company: Affymax Inc.
Industry: Medical - Biomedical and Genetics
Company: Affymax Inc.
Industry: Medical - Biomedical and Genetics
Positive Omontys Read-Through from Fresenius FY2Q12 Earnings
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Affymax Inc.
Industry: Medical - Biomedical and Genetics
Positive Omontys Read-Through from Fresenius FY2Q12 Earnings
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Affymax Inc.
Industry: Medical - Biomedical and Genetics
Company: Affymax Inc.
Industry: Medical - Biomedical and Genetics
Affymax Reaches Supply Agreement with Fresenius; Penetration of the LDOs Begins
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Affymax Inc.
Industry: Medical - Biomedical and Genetics
Affymax Reaches Supply Agreement with Fresenius; Penetration of the LDOs Begins
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Affymax Inc.
Industry: Medical - Biomedical and Genetics
Company: Affymax Inc.
Industry: Medical - Biomedical and Genetics
Survey of Dialysis Providers Indicate Significant Number of Early Adopters Likely for Omontys
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Affymax Inc.
Industry: Medical - Biomedical and Genetics
Survey of Dialysis Providers Indicate Significant Number of Early Adopters Likely for Omontys
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Affymax Inc.
Industry: Medical - Biomedical and Genetics
Takeaways from Takeda 2014 Mid-Range Plan Presentation for Omontys
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Affymax Inc.
Industry: Medical - Biomedical and Genetics
Takeaways from Takeda 2014 Mid-Range Plan Presentation for Omontys
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Affymax Inc.
Industry: Medical - Biomedical and Genetics
Company: Affymax Inc.
Industry: Medical - Biomedical and Genetics
Reports FY1Q12, While Investors Look for Insight into Launch
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Affymax Inc.
Industry: Medical - Biomedical and Genetics
Reports FY1Q12, While Investors Look for Insight into Launch
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M